Haibin Luo

Haibin Luo

AstraZeneca
在 astraZeneca.com 的电子邮件经过验证
被引用次数：1797
Downstream process development mAb self-association phase separation process-related impurity safety ris
Iraj Ghazi

Iraj Ghazi

Oxford Biomedica (US) LLC
被引用次数：1430
Gene Therapy Downstream Process Development
Ankit Gupta

Ankit Gupta

Principal Bioprocess Scientist I, Arcellx
在 arcellx.com 的电子邮件经过验证
被引用次数：798
Cancer Immunotherapy Protein Engineering Biophysics Structural Biology Downstream Process Development
Hemanta Adhikary

Hemanta Adhikary

Research Associate, Cell and Molecular Medicine, University of Ottawa
在 carleton.ca 的电子邮件经过验证
被引用次数：552
Oncology DNA repair Protein Biochemistry Downstream process development Tumor hypoxia
Duy Tien Ta

Duy Tien Ta

GSK
在 gsk.com 的电子邮件经过验证
被引用次数：487
mRNA vaccine downstream process development
Yong Won Shin

Yong Won Shin

KoBioLabs Inc.
在 kobiolabs.com 的电子邮件经过验证
被引用次数：362
Downstream process development therapeutic proteins monoclonal antibody
Sih-Yao Chow

Sih-Yao Chow

Amgen, Thousand Oaks, CA, USA
在 amgen.com 的电子邮件经过验证
被引用次数：231
Protein Engineering and Purification Formulation Development Downstream Process Development
Ling Zhang

Ling Zhang

Biogen, Rensselaer Polytechnic Instistute, Colorado State University, Shandong University
在 colostate.edu 的电子邮件经过验证
被引用次数：158
Downstream Process Development Antibody Engineering Protein Biochemistry Plant Biology
Sayed Golam Mohiuddin

Sayed Golam Mohiuddin

Postdoctoral Research Fellow, University of Houston
在 uh.edu 的电子邮件经过验证
被引用次数：140
Downstream process development Drug Discovery High-throughput Screening Antibody therapeutics
Magfur Alam

Magfur Alam

Bristol Myers Squibb
在 rpi.edu 的电子邮件经过验证
被引用次数：129
Antibody stability formulation high-throughput screening downstream process development
1 - 10